Dana-Farber Phase 1 Study Explores Toxicity Reduction in Combination of Trastuzumab Deruxtecan and Olaparib in Advanced HER2-Expressing Malignancies | Newswise
Dana-Farber Phase 1 Study Explores Toxicity Reduction in Combination of Trastuzumab Deruxtecan and Olaparib in Advanced HER2-Expressing Malignancies | Newswise
2 周前
newswise.com
Emerging targeted therapy combination strategies in genitourinary malignancies
Emerging targeted therapy combination strategies in genitourinary malignancies
2024年12月19日
reachmd.com
Kilovoltage Radiotherapy for Malignancies On and Just Below the Skin - Xstrahl
Kilovoltage Radiotherapy for Malignancies On and Just Below the Skin - Xstrahl
1 周前
xstrahl.com
Dr Miller on the Use of NK Cell Therapy in Hematologic Malignancies | OncLive
Dr Miller on the Use of NK Cell Therapy in Hematologic Malignancies | OncLive
2024年8月16日
onclive.com
Dr. Ailawadhi on the Results of a First-in-Human Study of Lisaftoclax in Hematologic Malignancies | OncLive
Dr. Ailawadhi on the Results of a First-in-Human Study of Lisaftoclax in Hematologic Malignancies | OncLive
2021年9月20日
onclive.com
An Overview of B-Cell Malignancies | AJMC
An Overview of B-Cell Malignancies | AJMC
2020年1月21日
ajmc.com
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
2020年7月19日
reachmd.com
Dr. Narkhede on Siltuximab for CRS and ICANS in Hematologic Malignancies | OncLive
2023年2月16日
onclive.com
Comparison of Nationally Representative Samples of Rasburicase vs Allopurinol Post-Hyperuricemia Monotherapy in Hematological Malignancies: Significant Reduction in Tumor Lysis Syndrome Mortality with Rasburicase | OncLive
2022年10月14日
onclive.com
Rate of Atrial Fibrillation in Patients With B-Cell Malignancies Who Undergo Treatment With Zanubrutinib | OncLive
2022年12月8日
onclive.com
0:29
New chemotherapy-free approaches for the treatment of lymphoid malignancies
已浏览 12 次2019年8月28日
bilibiliknnstack
Protein Inhibition Found to Sensitize Aggressive Lymphoma to Therapy | Immunology
1 周前
labroots.com
The UCL CAR T programme
2019年4月11日
ucl.ac.uk
Introduction to a review series on hematologic disease at older age
2018年2月1日
ashpublications.org
NYCBS Central Park Dr. Gruenstein
2022年1月8日
nycancer.com
Sam Lubner, MD
2025年4月8日
uwhealth.org
2:02
靶向肝细胞癌及免疫抑制微环境双特异性工程T细胞构建及应用
已浏览 1029 次2024年9月8日
bilibiliiGEM-SMU-China
Malignant
已浏览 2025 次8 个月之前
pathologyoutlines.com
Felix G. Fernandez, MD | Winship Cancer Institute of Emory University
2024年5月18日
emory.edu
Dissecting the Cellular Pathways Behind CAR T Cell Therapy
2024年12月16日
azolifesciences.com
Dr. Gulley Discusses a Phase II Study of Olaparib and Durvalumab in mCRPC | OncLive
2018年2月10日
onclive.com
Thank you to presenter Dr. Kami Maddocks, from The Ohio State University Medical Center, for contributing to Catalytic Health’s Canadian Hematology Today Symposium on B-Cell Malignancies! | Catalytic Health
1 周前
linkedin.com
Thomas B. Alexander - UNC Lineberger Comprehensive Cancer Center
6 个月之前
unclineberger.org
33:52
【医学】肺癌靶向治疗的进展与展望Targeted Therapies in Lung Cancer 2.0 Advances and Promises英文无字幕
已浏览 1427 次2020年11月16日
bilibili陶土星星
Chad V. Pecot - UNC Lineberger Comprehensive Cancer Center
6 个月之前
unclineberger.org
Cytokine “Armored” CAR-T Cells: Engineering the Next Generation of Cellular Immunotherapy
1 周前
marinbio.com
Host Genetics Identify Candidate Mechanisms of Cancer Immunotherapy Resistance
2024年9月5日
labroots.com
Exosomes: the key of sophisticated cell–cell communication and targeted metastasis in pancreatic cancer
2024年4月2日
nih.gov
1:14
【美迪西请回答】KRAS 突变与癌症的关系（KRAS Mutations and Cancer）
已浏览 62 次2024年2月7日
bilibili美迪西
展开